US20050171167A1 - Process and formulation containing epothilones and analogs thereof - Google Patents

Process and formulation containing epothilones and analogs thereof Download PDF

Info

Publication number
US20050171167A1
US20050171167A1 US10/979,958 US97995804A US2005171167A1 US 20050171167 A1 US20050171167 A1 US 20050171167A1 US 97995804 A US97995804 A US 97995804A US 2005171167 A1 US2005171167 A1 US 2005171167A1
Authority
US
United States
Prior art keywords
ph
selected
alkyl
pharmaceutical preparation
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/979,958
Inventor
Thomas Haby
Uday Gogate
Vijay Naringrekar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
R-PHARM US OPERATING LLC
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US51702003P priority Critical
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Priority to US10/979,958 priority patent/US20050171167A1/en
Assigned to BRISTOL-MYERS SQUIBB COMPANY reassignment BRISTOL-MYERS SQUIBB COMPANY ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: GOGATE, UDAY S., HABY, THOMAS A., NARINGREKAR, VIJAY H.
Publication of US20050171167A1 publication Critical patent/US20050171167A1/en
Assigned to R-PHARM US OPERATING LLC reassignment R-PHARM US OPERATING LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BRISTOL-MYERS SQUIBB COMPANY
Application status is Abandoned legal-status Critical

Links